On the HCPLive Hidradenitis Suppurativa condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatology research, treatment, and drug development.
April 01, 2025
Article
These data highlight the susceptibility loci shared between HS and other inflammatory diseases among those with this condition.
March 18, 2025
Video
This interview with Christopher Sayed, MD, features a discussion about his team’s recent findings on bimekizumab for hidradenitis suppurativa.
March 17, 2025
Article
These pivotal phase 3 data on povorcitinib were the results of the STOP-HS clinical trial, with results suggesting both efficacy and safety for hidradenitis suppurativa.
March 10, 2025
Article
These data presented at AAD 2025 indicate sustained 2-year disease control in key hidradenitis suppurativa (HS) symptoms with bimekizumab-bkzx treatment.
March 09, 2025
Video
This interview with Chovatiya highlights his portion of the ‘Skin of Color’ talk at the American Academy of Dermatology conference.
March 08, 2025
Video
Data from AAD 2025 examine the effect of GLP-1 RAs on HS among patients with overweight or obesity.
February 27, 2025
Article
These data point to the necessity of quality and usability when using smartphone photographs of skin conditions in emergency departments.
February 26, 2025
Article
These data provide a potential option for those suffering from hidradenitis suppurativa, as off-label treatment with botulinum toxin type X led to positive findings in patients.
February 19, 2025
Article
This analysis highlights the major risk factors resulting in limited use of oral JAKi for patients with hidradenitis suppurativa, including smoking, obesity, hypertension, and age.
February 15, 2025
Article
These data expand upon existing literature on pediatric HS and racial differences among patients based on management, presentation, and severity.